These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 22504769)
1. Surgical aspects in the treatment of adrenocortical carcinomas in children: data of the GPOH-MET 97 trial. Hubertus J; Boxberger N; Redlich A; von Schweinitz D; Vorwerk P Klin Padiatr; 2012 Apr; 224(3):143-7. PubMed ID: 22504769 [TBL] [Abstract][Full Text] [Related]
2. Systemic treatment of adrenocortical carcinoma in children: data from the German GPOH-MET 97 trial. Redlich A; Boxberger N; Strugala D; Frühwald MC; Leuschner I; Kropf S; Bucsky P; Vorwerk P Klin Padiatr; 2012 Oct; 224(6):366-71. PubMed ID: 23143764 [TBL] [Abstract][Full Text] [Related]
3. Mitotane treatment for adrenocortical carcinoma: an overview. De Francia S; Ardito A; Daffara F; Zaggia B; Germano A; Berruti A; Di Carlo F Minerva Endocrinol; 2012 Mar; 37(1):9-23. PubMed ID: 22382612 [TBL] [Abstract][Full Text] [Related]
4. Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. Gonzalez RJ; Tamm EP; Ng C; Phan AT; Vassilopoulou-Sellin R; Perrier ND; Evans DB; Lee JE Surgery; 2007 Dec; 142(6):867-75; discussion 867-75. PubMed ID: 18063070 [TBL] [Abstract][Full Text] [Related]
6. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. Michalkiewicz E; Sandrini R; Figueiredo B; Miranda EC; Caran E; Oliveira-Filho AG; Marques R; Pianovski MA; Lacerda L; Cristofani LM; Jenkins J; Rodriguez-Galindo C; Ribeiro RC J Clin Oncol; 2004 Mar; 22(5):838-45. PubMed ID: 14990639 [TBL] [Abstract][Full Text] [Related]
7. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist. Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis, treatment and outcome of adrenocortical cancer. Mihai R Br J Surg; 2015 Mar; 102(4):291-306. PubMed ID: 25689291 [TBL] [Abstract][Full Text] [Related]
14. Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. Berruti A; Terzolo M; Sperone P; Pia A; Della Casa S; Gross DJ; Carnaghi C; Casali P; Porpiglia F; Mantero F; Reimondo G; Angeli A; Dogliotti L Endocr Relat Cancer; 2005 Sep; 12(3):657-66. PubMed ID: 16172198 [TBL] [Abstract][Full Text] [Related]
15. Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; Kerkhofs T; Williams AR; Ardito A; Leboulleux S; Volante M; Deutschbein T; Feelders R; Ronchi C; Grisanti S; Gelderblom H; Porpiglia F; Papotti M; Hammer GD; Allolio B; Terzolo M Eur Urol; 2014 Apr; 65(4):832-8. PubMed ID: 24268504 [TBL] [Abstract][Full Text] [Related]
16. Surgical aspects in the treatment of patients with unilateral wilms tumor: a report from the SIOP 93-01/German Society of Pediatric Oncology and Hematology. Fuchs J; Kienecker K; Furtwängler R; Warmann SW; Bürger D; Thürhoff JW; Hager J; Graf N Ann Surg; 2009 Apr; 249(4):666-71. PubMed ID: 19300220 [TBL] [Abstract][Full Text] [Related]
17. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884 [TBL] [Abstract][Full Text] [Related]